1. Limiting Free Pricing of New Innovative Drugs After Launch: A Necessity for Payers?

   • Afschin Gandjour

   Editorial 04 June 2016 Pages: 507 - 509

2. Supporting Medicare Health, Equity and Efficiency in Australia: Policies Undermining Bulk Billing Need to Be Scrapped

   • Simon Eckermann
   • Lynnaire Sheridan

   Commentary 20 July 2016 Pages: 511 - 514

3. The Urolift System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A NICE Medical Technology Guidance

   • Alistair Ray
   • Helen Morgan
   • Grace Carolan-Rees

   Review Article Open access 30 January 2016 Pages: 515 - 526

4. Health Economic Evaluations of Sofosbuvir for Treatment of Chronic Hepatitis C: a Systematic Review

   • Miriam Luhnen
   • Siw Waffenschmidt
   • Gloria Hanke

   Systematic Review 21 June 2016 Pages: 527 - 543

   

5. Paucity and Inconsistency: A Systematic Review and Critique of Budget Impact Analyses of Disease-Modifying Therapies for Multiple Sclerosis in the UK and the Implications for Policy in the UK

   • Stephen Montgomery
   • Jeanette Kusel
   • Nicholas Adlard

   Systematic Review 29 April 2016 Pages: 545 - 558

   

6. A Qualitative Evaluation of Program Budgeting and Marginal Analysis in a Canadian Pediatric Tertiary Care Institution

   • Neale Smith
   • Craig Mitton
   • Shashi Ashok Gujar

   Original Research Article 11 June 2016 Pages: 559 - 568

7. Barrier to Access or Cost Share? Coinsurance and Dental-Care Utilization in Colombia

   • Lucas Higuera
   • Sergio Iván Prada

   Original Research Article 22 June 2016 Pages: 569 - 578

8. Cost Effectiveness of the Long-Acting β₂-Adrenergic Agonist (LABA)/Long-Acting Muscarinic Antagonist Dual Bronchodilator Indacaterol/Glycopyrronium Versus the LABA/Inhaled Corticosteroid Combination Salmeterol/Fluticasone in Patients with Chronic Obstructive Pulmonary Disease: Analyses Conducted for Canada, France, Italy, and Portugal

   • M. Reza Maleki-Yazdi
   • Mathieu Molimard
   • David Price

   Original Research Article 11 August 2016 Pages: 579 - 594

   

9. Care Appropriateness and Health Productivity Evolution: A Non-Parametric Analysis of the Italian Regional Health Systems

   • Paolo Mancuso
   • Vivian Grace Valdmanis

   Original Research Article 22 July 2016 Pages: 595 - 607

   

10. Cost of Purchased Versus Produced Plasma from Donor Recruitment Through Transfusion

    • Katherine M. Prioli
    • Laura T. Pizzi
    • Plasma Cost Focus Group

    Original Research Article 08 July 2016 Pages: 609 - 617